A Novel High-Content Flow Cytometric Method for Assessing the Viability and Damage of Rat Retinal Ganglion Cells by Chang, Zhi-Yang et al.
A Novel High-Content Flow Cytometric Method for
Assessing the Viability and Damage of Rat Retinal
Ganglion Cells
Zhi-Yang Chang
1, Da-Wen Lu
2, Ming-Kung Yeh
3, Chiao-Hsi Chiang
1,4*
1Graduate Institute of Life Sciences, National Defense Medical Center, Neihu, Taipei, Taiwan, 2Department of Ophthalmology, Tri-Service General Hospital, National
Defense Medical Center, Neihu, Taipei, Taiwan, 3Institute of Preventive Medicine, National Defense Medical Center, Sanhsia, Taipei, Taiwan, 4School of Pharmacy,
National Defense Medical Center, Neihu, Taipei, Taiwan
Abstract
Purpose: The aim of the study was to develop a high-content flow cytometric method for assessing the viability and
damage of small, medium, and large retinal ganglion cells (RGCs) in N-methyl-D-aspartic acid (NMDA)-injury model.
Methods/Results: Retinal toxicity was induced in rats by intravitreal injection of NMDA and RGCs were retrogradely labeled
with Fluoro-Gold (FG). Seven days post-NMDA injection, flatmount and flow cytometric methods were used to evaluate
RGCs. In addition, the RGC area diameter (D(a)) obtained from retinal flatmount imaging were plotted versus apparent
volume diameter (D(v)) obtained from flow cytometry for the same cumulative cell number (sequentially from small to large
RGCs) percentile (Q) to establish their relationship for accurately determining RGC sizes. Good correlation (r=0.9718) was
found between D(a) and apparent D(v). Both flatmount and flow cytometric analyses of RGCs showed that 40 mM NMDA
significantly reduced the numbers of small and medium RGCs but not large RGCs. Additionally, flow cytometry showed that
the geometric means of FG and thy-1 intensities in three types of RGCs decreased to 90.9662.24% (P,0.05) and
91.7861.89% (P.0.05) for small, 69.6262.11% (P,0.01) and 69.0762.98% (P,0.01) for medium, and 69.6866.48% (P,0.05)
and 69.9166.23% (P,0.05) for large as compared with the normal RGCs.
Conclusion: The established flow cytometric method provides high-content analysis for differential evaluation of RGC
number and status and should be useful for the evaluation of various models of optic nerve injury and the effects of
potential neuroprotective agents.
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Introduction
Retinal ganglion cells (RGCs) are neurons that receive visual
information from photoreceptors via intermediate neurons and
transmit messages to the brain. Several experimental models,
including ischemia reperfusion, optic nerve injury, intravitreal
excitatory amino acid injection and ocular hypertension, have
been used to investigate pathogenic processes of RGCs [1]. A
combination of retrograde labeling and retinal flatmount is
frequently applied to quantify RGCs in intervention-induced
RGC toxicity. Several neuronal tracers, such as fluoro-Gold (FG)
[2], di-I (1, 1-dioctadecyl-3, 3, 39,3 9-tetramethyl-indocarbocya-
nine perchlorate), and fast blue have been used to label RGCs [3].
FG is one of the most important tracing agents. After injecting the
FG tracer into superior colliculi, the tracer is transported in a
retrograde way through the optic nerve to obtain FG-labeled
RGCs up to 85% [4]. Image-analysis software is then used to
count the RGCs in a high-throughput and size-differentiated
fashion [5], [6]. The FG-tracer method provides a reliable
measurement to determine the number of RGCs, but no further
information regarding the function or damage of RGCs is
obtained. Additionally pattern electroretinography can be used
for determining the function of RGCs in vivo, but the
methodology is limited only qualitatively measuring the overall
RGC function [7].
In rat, three different sizes of RGCs, including large, medium,
and small RGCs, have been established. These correspond to
alpha, beta, and gamma RGCs, respectively, in morphological
classification [8], [9]. Despite the different characteristics of large,
medium, and small RGCs, most investigations report RGC
damage combining them together. This is primarily because a
feasible and convenient method for separating three groups of
RGCs to evaluate their damage independently is lacking. Thus, a
quantitative method for rapidly evaluating the number and
damage of large, medium, and small RGCs in pharmacological
studies is highly desired.
Currently, high-content analytical technology is applied to
evaluate multiple biochemical and morphological properties in a
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of high-content analysis. Flow cytometric signals provide rich
information about cell features. For instances, forward scatter
(FSC) correlates with cell volume; side scatter (SSC) corresponds to
internal complexity; and the signals of fluorescence (FL) represent
characters and intensities of fluorescent-labeled cells [10].
Although, flow cytometry has been applied for assessing the
liability of rat RGCs [11], however, the method alone does not
obtain additional information about the damage of survived
RGCs. The goal of this study was to develop a flow cytometric
method associated with biomarkers and neuronal tracers for
assessing the viability and damage of small, medium, and large
RGCs in an NMDA-induced rat retinal damage model. Thy-1 is
primarily expressed by RGCs within the retina, some RGC
stressors, including increased IOP [12], [13], optic nerve crush
[12], [13], [14], ischemia [15], [16] and intravitreal injection of
excitatory amino acid [12], [15], [16] have been shown to
decrease the levels of thy-1 mRNA and protein in RGCs. The
decrease in thy-1 mRNA and protein precedes and is greater than
the RGC loss, suggesting that thy-1 is an early marker of RGC
stress. [1], [12], [14]. In this study, thy-1 was used as a serrogate
marker for RGC status. Retrograde transport of FG is related to
the transporting ability of RGC axons [17], the intensity of the FG
in RGCs was assayed to evaluate the damage status of RGC
axons. The acquired data, FSC and different fluorescences of flow
cytometry, were used to analyze the biophysical and biochemical
features of RGCs.
Methods
Animals
Male Wistar rats (Taiwan National Laboratory Animal Center,
Taipei, Taiwan) weighing between 225 and 250 g, were housed in
a temperature-controlled (21–22uC) environment under a 12-h
light-dark cycle. All studies were handled in accordance with the
Association for Research in Vision and Ophthalmology Statement
on the Use of Animals in Ophthalmic and Vision Research. The
protocol was approved by the Institutional Animal Care and Use
Committee of National Defense Medical Center (Permit number:
IACUC-07-175 and IACUC-08-209).
Drug treatment
Neurotoxicity was induced with NMDA (Sigma, St. Louis, MO)
as previously reported [18]. Briefly, rats were anesthetized with a
mixture of ketamine hydrochloride (50 mg/kg, Nang Kuang
Pharmaceutical, Tainan, Taiwan) and xylazine hydrochloride
(13.3 mg/kg, Sigma, St. Louis, MO). After the application of
topical 0.5% proparacaine hydrochloride (Alcon Lab, Fort Worth,
TX), an intravitreal injection of 2 mL NMDA (40 mM) prepared
in BSS PLUSH solution (Alcon Lab, Fort Worth, TX) was
performed in the right eye of each rat using a 30-gauge needle
connected to a 10-mL microsyringe (Hamilton, Reno, NV). The
solution was injected into the sclera at approximately 1 mm
behind the limbus. The BSS PLUSH solution was used as a vehicle
control and injected into the left eye.
Retrograde labeling of retinal ganglion cells
RGCs were labeled with FG (Sigma, St. Louis, MO) by
injecting the FG solution into the superior colliculi using a
stereotaxic device (Stoelting, Wood Dale, IL) as described
previously [19], [20]. Briefly, four days post-NMDA injection,
rats were first anesthetized with the ketamine/xylazine mixture
and the skin over the cranium was incised to expose the scalp. Two
vertical holes, 1 mm in diameter, were drilled on both sides of the
skull with a dentist’s drill 6 mm posterior to the bregma and
1.5 mm lateral to the midline. Two microliter of 3% FG solution
was delivered by using a micropipette at depths of 3.8, 4.0 and
4.2 mm from the bone surface.
Retinal flatmount imaging and FG-labeled RGC counting
Seven days post-NMDA injection, the rats were euthanized with
CO2 and the eyes were immediately enucleated. The retinas were
dissected and fixed in 4% paraformaldehyde (Sigma, St. Louis,
MO) for 1 hour. After phosphate buffered saline (PBS) washing,
retinal flatmounts were prepared by making four radial incisions
and placing the retinas on slides in 10% glycerol (Sigma, St. Louis,
MO) in PBS. For RGC counts, the retinal slides were observed
under a fluorescence microscope (Olympus BX-50, Olympus
Optical, Tokyo, Japan) using UV excitation (330–385 nm) and a
barrier filter (420 nm). Digital images were taken using a CCD
camera (SPOT, Diagnostic Instruments, Sterling Heights, MI).
Each retina was visually divided into four quadrants (superior,
inferior, nasal and temporal). Quadrants were further divided into
central (0.8–1.2 mm from the optic disc), middle (1.8–2.2 mm
from the optic disc) and peripheral regions (0.8–1.2 mm from the
retinal border). At each region, two fields (2006200 mm
2) were
counted. Two methods, either manual or automatic counts, were
used to quantify RGCs. For automatic counts, the digital images
were processed using Image J (http://rsbweb.nih.gov/nih-image/,
U.S. National Institutes of Health, Bethesda, MD) and the RGB
(red-green-blue) images were converted to 8-bit grayscale for
binary counting [21]. The RGCs were classified into three groups
based on soma sizes described previously (small: ,9.4 mm;
medium: 9.4–12.6 mm; and large: .12.6 mm) [8]. RGC density
was expressed as the number of RGCs per square millimeter of the
counted retina area.
Double immunofluorescence labeling and terminal
uridine deoxynucleotidyl transferase dUTP nick end
labeling
To prepare retinal cell suspension, the dissected retinas were
incubated in papain solution (contained 20 U/mL papain, 1 mM
L-cystein, 0.5 mM EDTA and 200 U/mL DNase I [Sigma, St.
Louis, MO] in Earle’s balanced salt solution [EBSS, Invitrogen,
Carlsbad, CA]) at 37uC for 40 minutes. The retinas were
transferred to ovomucoid-BSA buffer (1 mg/mL ovomucoid,
1 mg/mL BSA, and 100 U/mL DNase I in EBSS) for 5 minutes
at 37uC. Then, tissues were gently triturated through a plastic
pipette until dispersed and the retinal cells were fixed with 2%
paraformaldehyde in PBS for 20 minutes at room temperature.
The cells were centrifuged and resuspended in PBS containing
0.4% triton X-100 (Sigma, St. Louis, MO) and 1% BSA was
added to block unspecific binding of antibodies. Each sample was
subsequently centrifuged and resuspended in DNA-labeling
solution (APO-BrdU
TM TUNEL Assay Kit; Invitrogen, Carlsbad,
CA) for 1 hour at 37uC to label DNA strand breaks in apoptotic
cells. The cells were then incubated with rabbit anti-Fluoro-Gold
antibody (1:100, Millipore, Bedford, MA) mouse peridinin-
chlorophyll protein (PerCP)-labeled anti-Thy1.1 antibody (1:100,
BD Biosciences, Franklin Lakes, NJ) and FITC-labeled anti-BrdU
antibody (1:200, eBioscience, San Diego, CA) for 30 minutes.
After washing with PBS, the cells were incubated with goat anti-
rabbit IgG phycoerythrin-R (PE) conjugated antibody (1:200,
Santa Cruz Biotechnology, Santa Cruz, CA) for 30 minutes. The
cells were then washed with PBS, resuspended in 1 mL PBS
containing 0.1% triton X-100. The total number of retinal cells
was counted using a hemacytometer (Bright-Line, Reichert,
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flow cytometry.
Flow cytometry
Retinal cells were evaluated using a flow cytometer (Facscaliber;
Becton Dickinson, San Jose, CA). The measurement conditions
were optimized based on preliminary studies with following
settings: FSC value for reflecting cell volume: voltage E00,
amplifier gain 2.3; SSC value for reflecting cytoplasmic structure:
voltage 400, amplifier gain 2.0; FL1 reflecting green labeled
fluorescence intensity (FITC): voltage 350; FL2 reflecting labeled
orange fluorescence intensity (PE): voltage 350; FL3 reflecting
labeled red fluorescence intensity (PerCP): voltage 470; and flow
rate: high. The compensation values determined from CaliBRITE
three-color kit (BD Biosciences, Franklin Lakes, NJ; three beads
each with one marker, FITC, PE or PerCP, separately; for
assessing single color bead: each bead 20 mL wtih 980 mL PBS; the
mixture of three color beads: 3620 mL beads with 940 mL PBS)
were set as follows. FL1–%FL2: 0.7%; FL2–%FL1: 20.0%; FL2–
%FL3: 0.0%; and FL3–%FL2: 17.5%.
Cell sizes were estimated from the FSC signals using the
calibration curve established by 6, 10, 15 and 20 mm-diameter of
polystyrene microspheres (20 mL microsphere solution+980 mL
PBS) (Polysciences, Warrington, PA). For each sample, 10,000
cells were counted automatically. Incubated cells without the
fluorescence conjugated antibody served as the blank. FG intensity
and Thy1.1 expression were evaluated as geometric means of FL2
and FL3 fluorescence intensities, respectively. The fluorescence
intensity was determined and the results were processed by
CellQuest Pro software (Becton Dickinson, San Jose, CA) and FCS
Express V3 (De Novo Software, Los Angeles, CA).
Correlation between flatmount imaging and flow
cytometry data
RGC area diameters (D(a)) of control group were calculated
from the area values of flatmount imaging and automatic counts.
The projecting area (A) equation of a circle (A=pD
2/4…eq.1) was
used for the calculation. D(a, Q) was defined as a area diameter for
the cumulative cell number (sequentially from small to large
RGCs) percentile (Q) of the determined RGCs with size under the
diameter. D(a, Q) values of RGCs in control group for Q at 5, 20,
40, 60, 80, and 95% were obtained from the data of flatmount
imaging and automatic counts. Apparent volume diameters (D(v))
of RGCs were estimated from the FSC values determined from the
flow cytometer by substituting these values into the established
calibration curve of the standard microspheres. Consequently,
apparent D(v, Q) values of control group for Q at 5, 20, 40, 60, 80,
and 95% were obtained. The relationship of D(a, Q) and apparent
D(v, Q) was also analyzed.
Statistical analysis
All results were expressed as mean 6 standard error of the
mean (SEM). The density and percentage of each RGC group in
NMDA-injured and control groups were statistically analyzed by
Student’s t-test using SPSS 12 software for Windows (SPSS Inc.,
Chicago, IL). The level of significance was set at P,0.05.
Results
Retinal flatmount imaging and counting
FG-labeled RGCs were examined and counted (Fig. 1A). The
quantifications of RGCs were obtained by image-analysis-software
and manual methods. The density of RGCs in the control group
obtained from two methods were similar (image-analysis-software
and manual methods, 1866634 cells/mm
2 vs. 1933628 cells/
mm
2, mean 6 SEM, n=8). The consistent results of the
retrograde labeled RGCs were obtained with very good precision
(coefficient of variation ,5%) in two counting methods. The
retinal area (estimated by Image J) was 59.4561.57 mm
2 (n=8)
associated with total RGC counts between 131,100 and 117,000
cells.
The size distribution of FG-labeled RGCs is shown in Fig. 1B.
Mean RGC densities and normalized frequency of small, medium,
and large RGCs were 1554631, 19564, and 117614 cells/mm
2
and 83.3161.64%, 10.4260.23% and 6.2660.75%, respectively
(n=8, Table 1).
On the seventh day post-intravitreal NMDA injection, total
RGC densities obtained from two counting approaches were
11076126 cells/mm
2 for the image-analysis-software method
(59.3466.76% of the control group, Table 1) and 10256132
cells/mm
2 for the manual method (53.0366.83% of the control
group) (P,0.001, n=8). The survival rate of RGCs with diameter
,10 mm was less than that of total RGCs (Fig. 1C). When
evaluating RGC survival rates, flatmount analysis showed that the
RGC densities of small and medium RGCs were significantly
affected to be reduced to 8726110 and 120619 cells/mm
2
(46.7465.92% and 6.4360.99% of total RGCs of control group,
P,0.01, n=8) (Table 1), but the large RGCs seemed invulnerable
to NMDA toxicity and no significant difference in RGC density
was observed between the two groups.
Preliminary analysis of flow cytometry
To validate the distinguishability of three channels in one
determination, three color beads (including FITC, PE, and PerCP-
labeled beads) were used to adjust the setting condition of flow
cytometer. Representative flow cytometric histograms of fluores-
cence-labeled beads are displayed in Fig. 2A–L. Among
histograms of FITC-labeled bead, FL-1H histogram exhibited
that peak of FITC-labeled bead (PeakFITC) was located on positive
region (M2) (Fig. 2A), and FH-2H and FH-3H histograms
exhibited that peakFITC shifted to negative region (M1) (Fig. 2B,
C). The same phenomena could be observed in histograms of the
other two beads (Fig. 2D–F, G–I). When evaluating histograms of
the mixture of three color beads, the following was noted. The
peakFITC heights of FL-1H, FL-2H and FL-3H histograms were in
the ratio of 100:35:8 (Fig. 2A–C). The peakPE heights of FL-1H,
FL-2H and FL-3H histograms were in the ratio of 44:100:39
(Fig. 2D–F). The peak identification of three color beads-mixed
histograms depended on position, peak height ratio and waveform.
The FL-1H, FL-2H, and FL-3H histograms of the mixture of
three color beads exhibited positive peaks of FITC, PE, and
PerCP-labeled beads, respectively (Fig. 2J–L), suggesting the
setting condition of flow cytometry could distinguish three
fluorescence colors. To avoid background fluorescence and non-
specific binding, two groups were used as negative controls [22],
[23]: (I). retinal cells with retrograde labeling but without
immunostaining (without primary and secondary antibodies) and
(II). retinal cells with retrograde labeling and non-specific staining
(fluorescence-conjugated secondary antibody alone). The results of
flow cytometric dot plots showed that .99.98% group I cells
(Fig. 2M–2N) and .99.90% group II cells (Fig. 2O, P) were in the
negative region (third quadrant, both X and Y intensity ,10
1).
These results suggested that background fluorescence and non-
specific binding was only little effect on the measurement of
positive cells. Commercial standard microspheres with various
sizes underwent FSC measurements using the same setting
condition in flow cytometry (Fig. 3A). The established flow
cytometric method yielded acceptable precision for FSC determi-
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shown). A linear equation was used to fit a calibration curve of
microsphere diameter versus FSC value: y=0.027x+2.16 (eq. 2),
where x=FSC value; y=microsphere diameter, with a unit of
micrometer. The fitted equation had good linear relationship
(r=0.9883, Fig. 3B) to be applied for calculating the D(v, Q) of
RGCs.
Correlation between the area diameter and apparent
volume diameter of RGCs
After the treatment of RGC samples just prior to flow
cytometric counting, these samples were also examined under a
fluorescence microscope as the flatmount method (Fig. 4). The
result of RGC size distribution was similar to the flatmount
counting. It suggested that the RGC sample treatment before flow
Figure 1. Flatmount quantification of rat RGCs by image analysis software. Seven days post-treatment with intravitreal injection of vehicle
(BSS as control) or NMDA solution. (A). Image of FG-labeled RGCs in flatmounted retina, bar=100 mm. (B). Soma size distribution histograms. The
histograms were generated by counting 10000 RGC cells and dividing into size groups with a 2 mm interval. RGC density was expressed as RGCs/mm
2
(mean 6 SEM, n=8). (C). RGC survival rates of different size groups after intravitreal NMDA (40 mM, 2 mL) treatment. Each point represents RGC
survival rate (%) based on the individual RGC size population of control group, the dashed line represents total RGC survival rate (%).
doi:10.1371/journal.pone.0033983.g001
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distribution of RGCs. The areas of RGCs (determined by
image-analysis software) in the control group for Q at 5, 20, 40,
60, 80, and 95% were 15.14, 17.30, 25.95, 36.77, 62.72, and
140.57 mm
2 corresponding to 4.39, 4.69, 5.75, 6.84, 8.94, and
13.38 mm (calculated by eq. 1) for the D(a, Q) of RGCs,
respectively. Flow cytometry revealed that the FSC values of
RGCs in the control group for Q at 5, 20, 40, 60, 80, and 95%
were 78, 104, 187, 290, 445, and 603 corresponding to 4.04, 4.86,
7.33, 10.28, 14.45, and 18.33 mm of apparent D(v, Q) (calculated
by eq. 2), respectively. There were 27.97% to 61.61% of
differences between D(a, Q) and apparent D(v, Q) (Table 2). The
relationship between D(a, Q) and apparent D(v, Q) is shown in Fig. 5.
An linear equation (y=1.61 x21.94…eq. 3, r=0.9718, x:D (a, Q);
y: apparent D(v, Q)) was fitted. The results indicated that RGC
soma sizes determined from flatmount imaging and flow
cytometry had good linear relationship. The sample preparing
process of retinal cell suspension for flow cytometric determination
did not obviously change RGC size distribution.
Effects of NMDA on survival rate and health of retinal
cells
The effects of NMDA on retinal cells were further evaluated by
flow cytometry. Representative flow cytometric dot plots of triple-
labeled retinal cells are displayed in Fig. 6. In control group, FG
2/
thy-1
+ cells (gate 1), which were considered to be non-RGC cells,
comprised 5.3162.66% of the total thy-1
+ cells; FG
+/thy-1
2 cells
(gate 2), which were also considered to be non-RGC cells,
comprised 2.0560.44% of the total FG
+ cells (n=6, Fig. 6A). In
NMDA group, FG
2/thy-1
+ cells comprised 6.0861.11% of the
total thy-1
+ cells; FG
+/thy-1
2 cells comprised 2.5360.36% of the
total FG
+ cells (n=6, Fig. 6H). FG/thy-1 double positive cells
were considered to be RGCs [24]. Furthermore, RGCs were
classified into three groups according to the projecting area of the
RGC soma. The area was sequentially converted into area
diameter (eq. 1), true volume diameter (eq. 3), and FSC values (eq.
2) as described in Table 2. The determined FSC values were then
used to classify three-group RGCs and non-RGC in flow
cytometry. The percentages of three-size FG
+/thy-1
2 cells among
each size of FG
+ cells were all ,6.59% (n=6, Fig. 6B, D) and
three-size FG
2/thy-1
+ cells among each size of thy-1
+ cells were
all ,5.34% (n=6, Fig. 6C, E). After NMDA treatment, the
number, FG intensity and thy-1 intensity of three-size non-RGC
did not have any significant differences (n=6, P.0.05, Fig. 6I, J)
compared to control group. These results suggested that non-
RGCs are only a minor effect on RGC quantification and damage
assessment.
Flow cytometry confirmed that NMDA treatment resulted in a
significant loss of small RGCs (58.7464.35% in FG
+ and
61.8964.24% in thy-1
+ RGCs, P,0.001) but not large RGCs
(n=6, Fig. 6K, L, Fig. 7A). Flow cytometry further showed that
the geometric means of FG intensity of normal small, medium,
and large RGCs were 19.3960.57, 27.4061.85 and 35.4464.01,
respectively. The coefficients of variation in FG intensity were
good precision but slightly higher as increasing the size of RGCs.
Following NMDA treatment, the percentages of the geometric
means of FG intensities for the three groups of live RGCs were all
significantly reduced (small: 90.9662.24%, P,0.05; medium:
69.6262.11%, P,0.01; and large 69.6866.48%, P,0.05) as
shown in Fig. 6K and Fig. 7B. After seven days of NMDA
treatment, the protein levels of thy-1 in medium and large live
RGCs were also significantly reduced. In comparison with the
control group, medium and large live RGCs expressed
69.0762.98% (P,0.05) and 69.9166.23% (P,0.05, n=6,
Fig. 6L, Fig. 7C) thy-1 levels, respectively. Seven days after
NMDA treatment, the number of TUNEL
+ RGCs did not show
any significant differences (Fig. 6F, G, M, N).
Discussion
While flow cytometry is the most widely used method for
determining cell number, cell size, and fluorescence intensity, the
method has not yet been employed in the evaluation of the overall
characterization of RGCs. The present study describes a novel
flow cytometric method to simultaneously evaluate the viability
and damage of large, medium, and small RGCs in a single
determination.
Some theories suggest that RGC axon degeneration and
somatic loss are sequential events. The pathological process might
be initiated by axon damage which consequently impairs the
retrograde transport pathway of neurotrophins leading to the
death of RGCs [25], [26]. To identify RGC pathological
conditions, various fluorescent tags have been used. In this study,
retrograde transport of a fluorescent dye and an immunostaining
technique that labeled RGCs and terminal uridine deoxynucleo-
tidyl transferase dUTP nick end labeling (TUNEL) were used for
detecting apoptotic cells. FG, a small-molecule fluorescent dye
with a molecular weight of 472, remains stable for more than two
weeks in stained neurons. In addition, FG has a commercially
available antibody for enhancing the visualization of stained
targets to avoid background interference in flow cytometric
analysis [22]. Hence, FG was chosen as a tracer for retrograde
labeling via the intact axons of RGCs. In turn, thy-1 is a specific
marker for RGCs. The marker is used to quantify RGCs via
immunohistochemistry and evaluate the health of RGCs under
toxic damage by measuring thy-1 mRNA [12], [15], [27]. Thy-1-
CFP (cyan fluorescent protein) transgenic mouse is an established
animal model which has been studied for simplifying the
quantification of RGCs [24], [28]. The available data suggest
that thy-1 is a suitable surface marker for identifying RGCs and
assessing RGC damage. In studying RGC toxic damage, some
researchers use reverse transcriptase PCR or western blot to
measure the level of total thy-1 mRNA or protein, respectively,
was used as a serrogate marker for total RGC status [12], [15],
[16]. Compared to previous studies, one advantage of the present
study is that the investigated flow cytometry technique is capable
of measuring thy-1 protein at the single-cell level. This advantage
is attributable to the flow cytometric capability of allowing a single
Table 1. Normalized frequency of rat RGCs in control and
NMDA-induced groups.
Group Normalized frequency (%)
Total RGCs Large RGCs Medium RGCs Small RGCs
Control 100.0061.84% 6.2660.75% 10.4260.23% 83.3161.64%
NMDA-
induced
59.3366.76%{ 4.4160.96% 6.4360.99%{ 46.7465.92%{
RGCs were classified as small, medium and large groups based on their soma
sizes: small=,9.4 mm; medium=9.4–12.6 mm; large=.12.6 mm (mean 6
standard error of the mean, n=8). The number of RGCs was normalized with
total RGCs of control group. Control and NMDA-induced groups were
statistically analyzed by the Student’s t-test. *P,0.05,
{P,0.01 and
{P,0.001.
doi:10.1371/journal.pone.0033983.t001
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PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e33983Figure 2. Preliminary analysis of flow cytometry. (A–L) Representative flow cytometric histograms of fluorescein isothiocyanate (FITC, Ex:
490 nm; Em: 520 nm)-labeled beads (A–C), phycoerythrin-R (PE, Ex: 495 nm; Em: 578 nm)-labeled beads (D–F), peridinin-chlorophyll protein (PerCP,
Ex: 490 nm; Em: 677 nm)-labeled beads (G–I) and the equal-amount mixture of three color beads (J–L). The FL-1H histogram (A) shows the positive
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tions as low as 10–100 pM [10].
The flow cytometric FSC signal of cell had been reported to be
proportional to cell volume. Apparent cell size can be obtained
from the FSC signal-volume calibration curve of known size
microspheres. Because the refractive index, surface features and
shape of particles, are also important factors to contribute to the
FSC signal, thus, the results of cell size determined from the
flatmount and flow cytometric methods might not be equal for
further explaining the deviation of measured cell size between two
methods. During well-controlled experimental condition, the size
distribution of rat RGCs was not changed in sample treatment
process. Therefore, the size of FG-labeled RGCs was measured via
microscopic imaging within a certain percentile which was also
used to apply in flow cytometric RGC sizing for dividing RGCs
into small, medium and large groups.
Rat RGCs were often classified by morphological analysis.
However, published data about the soma size distribution are
inconsistent [5], [8], [29]. The reasons for the inconsistency are
unclear, but could be due to labeling method (specific or non-
specific) and dye (well cellular uptake or not). The combination of
retrograde labeling and thy-1 immunostaining could exclude non-
specific cellular labeling. Thy-1
+/FG
2 and Thy-1
2/FG
+ cells,
which were considered to be non-RGC cells, were endothelial cells
and secondary FG-stained cells, respectively. Most Thy-1
+/FG
+
cells were RGCs, only few Thy-1
+/FG
+ cells were activated
microglial cells. Two kinds of Thy-1
+/FG
+ cells could be further
distinguished by morphology or cell markers (such as neurofli-
ment-L). Earlier studies indicated that thy-1
+/DiA
2 cells are only
3% of total thy-1 positive cells in transgenic mice, and activated
microglial cells are about 1.5% of total FG positive cells in rat.
[24], [30]. Our results together with pervious studies, suggest that
non-RGCs have only a minor effect on RGC quantification. It has
been reported that acute RGC shrinkage only occurs during RGC
apoptosis and apoptotic RGCs are rapidly cleaned up from the
retina [31]. In addition, some rat studies show that the number of
TUNEL-positive RGCs or apoptotic cells peaks at 24 hours and
decreases to baseline by 72 hours after intravitreal NMDA
injection [18], [19]. Our flow cytometric data TUNEL assay
showed that there were no significant differences between the
control and NMDA groups after seven days following intravitreal
treatment. Taken together, these results indicated that apoptotic
RGCs were rapidly cleaned up and RGC shrinkage was not a
significant factor on three groups of RGC counts at 72 hours after
peak of FITC-labeled beads (peakFITC) (in region M2, intensity .10
1); the FL-2H histogram (E) shows the positive peak of PE-labeled beads (peakPE); the
FL-3H histogram (I) shows the positive peak of PerCP-labeled beads (peakPerCP). The FL-1H (J), FL-2H (K), and FL-3H (L) histograms of the mixture of
three color beads show positive peaks of FITC, PE, and PerCP-labeled beads, respectively. (M–P) Representative flow cytometric dot plots of negative
controls. .99.98% retinal cells with retrograde labeling but without immunostaining (M, N), and .99.90% retinal cells with retrograde labeling and
non-specific staining (O, P) were in the negative region (third quadrant, both X and Y intensity ,10
1). Abbreviations: FL1-H: green fluorescence, 530/
30 nm bandpass filter; FL2-H: orange fluorescence, 585/42 nm bandpass filter; FL3-H: red fluorescence, .650 nm bandpass filter.
doi:10.1371/journal.pone.0033983.g002
Figure 3. Flow cytometric size calibration. (A) Overlay of
representative flow cytometric histograms of 6-, 10-, 15- and 20-mm-
diameter microspheres. (B) Linear relationship between standard
microsphere diameter and forward scatter (FSC) measurements. For
each particle population, the mean FSC value was determined in
triplicate.
doi:10.1371/journal.pone.0033983.g003
Figure 4. Fluorescence images of dissociated RGCs. Retinal cells
were dissociated with papain, fixed with 4% paraformaldehyde in PBS,
and stained with DAPI (blue). RGCs (arrowhead) were identified by
double immunocytochemistry with anti-neurofilament (NF)-L antibody
(green) and anti-thy-1 anitbody (red), bar=100 mm.
doi:10.1371/journal.pone.0033983.g004
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The hypothesis that there is a selective loss of RGC subtypes
under glaucomatous stress is widely debated. For example, some
studies report that small RGCs are lost after axotomy in adult rats
[32]. Retinal flatmount and cross-sectional studies indicate that
large RGCs are primarily lost in humans and monkeys with
elevated intraocular pressure (IOP) [33], [34], [35]. In the present
study, RGC quantitation by both flow cytometry and retinal
flatmount showed the selective loss of small RGCs in the face of
NMDA toxicity. These disparities could be attributed to different
experimental conditions, including the sources of insults and
animal species. Surprisingly, our flow cytometric data showed that
the changes in thy-1 level had opposite results to RGC loss in
NMDA toxicity. Previous studies involving psychophysical and
electrophysiological examinations failed to support the hypothesis
that there is selective dysfunction of large RGCs in patients with
elevated IOP [36], [37]. As for the discrepancy between
anatomical and functional data, studies addressing retinal
structure-function relationships help rationalize the discrepancy
as researchers have used two methods to analyze retinal structure
and function in glaucoma. Analyses showed that the level of RGC
dysfunction (or toxic damage) is more serious than structural
damage, such as retinal shrinkage or RGC loss, suggesting that
RGC dysfunction appears early. In other words, there is a lag time
between RGC dysfunction and RGC loss [12], [13], [38], [39].
Previous studies indicated that elevated IOP caused both large (M
cell) and small RGC (P cell) dysfunction [38], [39]. Thus, if the lag
time of large RGCs is shorter than that of small RGCs, selective
loss of large RGCs may be detected at the later stage. Our flow
cytometric method showed that small RGCs were primarily
dying during NMDA toxicity, but surviving small RGCs had less
stress damage than the large RGCs. This may be because the lag
time of large RGCs is longer than that of small RGCs in NMDA
toxicity.
Another explanation involves the threshold in apoptosis for the
three groups of RGCs. The thy-1 levels of normal RGCs were not
lower than threshold and the damaged RGCs, below the
threshold, had disappeared within initial 72 hours as their
fluorescence could not be observed or determined in our study.
In addition, previous studies have shown that the percentage
change of thy-1 level or RGC function is larger than the fraction of
RGC number loss in models of retinal damage [12], [15], [38],
[39]. This information indicates that the majority of live RGCs
were equal or higher than the threshold but that one portion of the
live RGCs was dysfunctional. Thus, if most large RGCs are lost
Table 2. Deviations of RGC size percentiles determined by flatmount and flow cytometry.
Area (mm
2) Area diameter (D(a), mm) Volume diameter (D(v), mm) FSC value Difference (%)
Cumulative RGC percentage
Q5 15.14
a 4.39
b 4.04
c 78
d 27.97
Q20 17.30 4.69 4.86 104 3.62
Q40 25.95 5.75 7.33 187 27.48
Q60 36.77 6.84 10.28 290 50.29
Q80 62.72 8.94 14.45 445 61.63
Q95 140.57 13.38 18.33 603 37.00
RGC group
Small RGCs 15–70 4.37–9.44 5.09–13.26
e 108–411
f -
Medium RGCs 70–125 9.44–12.62 13.26–18.38 411–601 -
Large RGCs 125- 12.62- 18.38- 601- -
Difference (%)=(volume diameter2area diameter)/area diameter6100%.
aRGC area was obtained from the flatmount method by using an image-analysis software.
bD(a, Q) was calculated from the circle area equation (eq. 1, 26(area/3.1416)
1/2).
cApparent D(v, Q): the RGC diameter was estimated by substituting its FSC value into the calibration curve of the standard microspheres (y=0.027 x+2.16, eq. 2, x=FSC
value; y=diameter).
dFSC value was obtained from the flow cytometric measurement of RGCs.
eD(v, Q): the RGC diameter was estimated by substituting D(a, Q) into the linear equation.
fCalculated FSC value: the FSC value was calculated from D(v) (eq. 2).
doi:10.1371/journal.pone.0033983.t002
Figure 5. Linear relationship between area diameter (D(a)) and
apparent volume diameter (D(v)) of normal RGCs. D(a) was
estimated by image-analysis software. Apparent (D(v)) was obtained by
substituting its FSC value in the calibration curve of the standard
microspheres (y=0.027x+2.16 x=FSC value; y=diameter). (D(a, 5),D (v, 5)),
(D(a, 20),D (v, 20)), (D(a, 40),D (v, 40)), (D(a, 60),D (v, 60)), (D(a, 80),D (v, 80)), and
(D(a, 95),D (v, 95)) were plotted to obtain the equation: y=1.61x21.94. D(v,
Q) and D(a, Q) represent the volume diameter and area diameter,
respectively at the cumulative cell size percentile of Q in total RGCs.
doi:10.1371/journal.pone.0033983.g005
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anatomical examination and functional examination in the
elevated IOP model will exist. Our flow cytometric analysis,
however, showed that large RGCs had greater mean fluorescence
intensities of FG and thy-1 than small RGCs indicating that large
RGCs appear more resistant to loss than small RGCs. This finding
was consistent with the NMDA model but was different from the
elevated IOP model. It is possible that large RGCs have a smaller
surface-to-volume ratio causing a more significant loss when IOP
is elevated [35]. Overall, the hypotheses suggest that the lag time
or fluorescence intensity of markers and their level change depend
on both the RGC population and the sources of insults. In
addition, it is necessary to evaluate both RGC structure and
function to obtain their relationships. The flow cytometric method
described herein evaluates the viability and damage of large,
medium, and small RGCs in a single determination.
The prevailing opinion regarding the primary site of damage in
glaucoma is the RGC axons located at optic nerve head. The loss
of the RGC soma occurs after axon damage in long-term duration
[25], [26], [40], [41]. In the present study, FG-labeled RGC loss
and the change of fluorescence intensity correlated closely with
that of thy-1-labeled RGCs, suggesting that the latency period
between axon damage and RGC soma loss is very short in NMDA
toxicity.
Even though the established flow cytometric method provides a
plethora of real-time data regarding RGCs, the method has some
limitations. One is that flow cytometry is only equipped with three
channels which limits 3 fluorescent tags to be evaluated
simultaneously. Another challenge is that the adjustment of
fluorescence compensation has become more difficult when
multiple color markers are used to label cells. In addition to
fluorescence parameters, FSC is another parameter of flow
Figure 6. Flow cytometric analysis of triple-labeled retinal cells. Representative flow cytometric dot plots of triple-labeled (TUNEL, FG, and
thy-1) cells of control group (A–G) and NMDA-induced group (H–N). RGCs and non-RGCs were evaluated by FG vs thy-1 labelings (A, H). Size of gated
FG
+/thy-1
2 (gate 1) and FG
2/thy-1
+ (gate 2) cells were evaluated by FSC vs FG labeling (B, I) and FSC vs thy-1 labeling (C, J), respectively. Small,
medium and large RGCs were evaluated by FSC vs FG labeling (D, K) and FSC vs thy-1 labeling (E, L). Apoptotic RGCs were evaluated by TUNEL vs FG
labelings (F, M) and TUNEL vs thy-1 labelings (G, N). Abbreviations: FL1-H=TUNEL; FL2-H=Fluoro-Gold; FL3-H=Thy-1; FSC-H=Forward scatter; s-, m-
and l-NRs=small, medium and large non-RGCs; s-, m- and l-RGCs=small, medium and large RGCs.
doi:10.1371/journal.pone.0033983.g006
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Perhaps further research could use biomarkers to confirm the
morphologic classification of the RGCs.
In conclusion, the established flow cytometric method provides
a high-content analysis for differentiating the loss and damage
among three groups of RGCs. The downstream effectors of
apoptotic damage and death pathways in each RGC group,
however, are unclear. In addition, RGC death is a complex
process involving more than one toxic insult. Further research is
needed to examine the effects of other toxic insults on RGC
groups by the established flow cytometric method and to explore
possible downstream effectors of apoptotic damage and death
pathways in each RGC group. This understanding may improve
the treatment of pharmacological neuroprotection.
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